The Case for a New National Program for the Development of Cancer Therapeutics-Reference-Cited by-同舟云学术

The Case for a New National Program for the Development of Cancer Therapeutics

Published:2001-06-15 Issue:12 Volume:19 Page:3142-3153
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Schein Philip S.¹

Affiliation:

1. From the International Network for Cancer Treatment and Research, United States Branch, Bryn Mawr, PA.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2001.19.12.3142

Reference12 articles.

1. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update

2. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

3. Schiff PB, Fant J, Horowitz SB: Promotion of microtuble assembly in vitro by Taxol. Nature 22: 665,1979

4. Christian MC, Pluda JM, Ho PTC, et al: Promising new agents under development by the Division of Cancer Treatments Diagnosis, and Centers of the National Cancer Institute. Semin Oncol 42: 219,1997-240,

5. An Information-Intensive Approach to the Molecular Pharmacology of Cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Survey of Therapeutic Trials for Metastatic Colorectal Cancer: Room for Improvement in the Critical Pathway;Journal of Clinical Oncology;2008-04-20

2. Lysosomal storage diseases: Natural history and ethical and economic aspects;Molecular Genetics and Metabolism;2006-07

3. Barriers to Efficient Development of Cancer Therapeutics;Clinical Cancer Research;2006-06-01

4. Treatment adherence and 6-mercaptopurine metabolites;Pediatric Blood & Cancer;2005

5. Identifying Agents to Test in Phase III Trials;Handbook of Anticancer Pharmacokinetics and Pharmacodynamics;2004